Pharmabiz13h
CRSIC concludes 23rd International Symposium in Mumbai with discussions on business potential of new drug delivery systems
Our Bureau, Mumbai Tuesday, March 18, 2025, 16:30 Hrs [IST] ...
Pharmabiz12h
Supriya Lifescience powers ahead with a New 5 MWp solar facility
Supriya Lifescience powers ahead with a New 5 MWp solar facility: Our Bureau, Mumbai Tuesday, March 18, 2025, 17:15 Hrs [IST] Supriya Lifescience Ltd., a cGMP-compliant company wi ...
Pharmabiz21h
Pharmalabchem Expo to be held in Goa from May 8 to 10
Exhivision Media has announced the fourteenth edition of Pharmalabchem Expo – India’s premier exhibition dedicated to the pharmaceutical, lab, and related industries. The event will be held from May 8 ...
Pharmabiz12h
EU approves AstraZeneca’s Imfinzi as monotherapy to treat adults with limited-stage small cell lung cancer
AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...
Pharmabiz13h
SOPPA appeals to NMC to formally recognise anaesthesiologists as competent physicians
SOPPA appeals to NMC to formally recognise anaesthesiologists as competent physicians: Our Bureau, Bengaluru Tuesday, March 18, 2025, 16:20 Hrs [IST] Scientific Programme of the S ...
Pharmabiz19h
Roche to present latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association 2025 conference
Roche to present latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association 2025 conference: Basel Tuesday, March 18, 2025, 11:00 Hrs [IST] ...
Pharmabiz14h
Botanic Healthcare expands ethical Berberine production amid rising demand
Botanic Healthcare expands ethical Berberine production amid rising demand: Our Bureau, Bengaluru Tuesday, March 18, 2025, 16:10 Hrs [IST] Botanic Healthcare, a global leader in t ...
Pharmabiz20h
AstraZeneca to buy in vivo cell therapy company, EsoBiotec for US$ 1billion
AstraZeneca to buy in vivo cell therapy company, EsoBiotec for US$ 1billion: Cambridge, UK Tuesday, March 18, 2025, 10:00 Hrs [IST] AstraZeneca, a global, science-led biopharmaceu ...
Pharmabiz18h
AstraZeneca inks license pact with Alteogen for subcutaneous formulations of multiple oncology assets
AstraZeneca inks license pact with Alteogen for subcutaneous formulations of multiple oncology assets: Cambridge, UK Tuesday, March 18, 2025, 12:00 Hrs [IST] AstraZeneca, a global ...
Pharmabiz13h
China NMPA approves Akeso's penpulimab for first-line treatment of nasopharyngeal cancer
China NMPA approves Akeso's penpulimab for first-line treatment of nasopharyngeal cancer: Hong Kong Tuesday, March 18, 2025, 17:00 Hrs [IST] Akeso Inc., a biopharmaceutical compan ...
Pharmabiz17h
Anocca announces authorisation of clinical trial application to start first in-human trial in advanced pancreatic cancer
Anocca announces authorisation of clinical trial application to start first in-human trial in advanced pancreatic cancer: Södertälje, Sweden Tuesday, March 18, 2025, 13:00 Hrs [ ...
Pharmabiz13h
PCRM reports swapping animal products for plant-based foods leads weight Loss
PCRM reports swapping animal products for plant-based foods leads weight Loss: Our Bureau, Bengaluru Tuesday, March 18, 2025, 16:40 Hrs [IST] Replacing animal products with plant- ...